Targeting toxic forms of α-synuclein with immunotherapy could alter the progression of Parkinson’s disease Julia Paik Practical Issues and Updates 18 October 2022 Pages: 467 - 471
Approach the treatment of acne in transgender patients with sensitivity and awareness Yvette N. Lamb Practical Issues and Updates 25 October 2022 Pages: 472 - 477
Recommend photoprotection for everyone including those with skin of colour Tina Nie Practical Issues and Updates 04 November 2022 Pages: 478 - 482
Approach the prevention of chemotherapy-induced nausea and vomiting in older patients with care Connie Kang Practical Issues and Updates 05 November 2022 Pages: 483 - 488
First reports of adverse drug reactions and drug interactions Drug Reactions and Interactions 18 October 2022 Pages: 489 - 489
Association between polypharmacy, patient-reported symptoms, and quality of life among nonalcoholic fatty liver disease patients in the United States Marwan AlrasheedJeff Jianfei GuoAna L. Hincapie Original Research Article 03 November 2022 Pages: 490 - 498
Correction to: Prevalence and predictors of inappropriate apixaban dosing in patients with non‑valvular atrial fibrillation at a large tertiary academic medical institution Hisham A. BadreldinLamya AlreshoudMohamed Salih Aziz Mohamed Correction 31 October 2022 Pages: 499 - 499
Correction: Difelikefalin in pruritus associated with chronic kidney disease: a profile of its use Yvette N. Lamb Correction 09 November 2022 Pages: 500 - 500